CASI PHARMACEUTICALS, INC. Proceeds from Sale of Intangible Assets
CASI PHARMACEUTICALS, INC. (CASIF) reported Proceeds from Sale of Intangible Assets of $500.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfIntangibleAssets · last filed 2026-05-15
| Period end | Proceeds from Sale of Intangible Assets 12 month |
|---|---|
| 2024-12-31 | $500.00K 20-F · filed 2026-05-15 |
| 2020-12-31 | $2.70M 20-F · filed 2023-04-26 |